Intercept Pharmaceuticals (ICPT) Prices IPO at $15 Per Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Medifast launches Trilivy, replacing its Optavia brand
Intercept Pharmaceuticals (ICPT) IPO Trades 26% Higher
October 11, 2012 11:39 AM EDTThe IPO for Intercept Pharmaceuticals, Inc., (Nasdaq: ICPT) opened for trading earlier at $19.40 after pricing 5,000,000 shares at $15, the high end of the expected $13-$15 range. Shares currently trade at $18.87.
BofA Merrill Lynch is acting as sole book-running manager for the... More
